Cognex Corporation (NASDAQ:CGNX – Get Free Report) declared a quarterly dividend on Wednesday, August 5th. Shareholders of record on Thursday, August 20th will be given a dividend of 0.085 per share by the scientific and technical instruments company on Thursday, September 3rd. This represents a c) dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Thursday, August 20th.
Cognex has decreased its dividend payment by an average of 0.3%annually over the last three years and has increased its dividend every year for the last 10 years. Cognex has a payout ratio of 31.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Cognex to earn $1.73 per share next year, which means the company should continue to be able to cover its $0.34 annual dividend with an expected future payout ratio of 19.7%.
Cognex Stock Down 1.1%
NASDAQ:CGNX opened at $70.71 on Thursday. The firm has a market capitalization of $11.77 billion, a price-to-earnings ratio of 84.18 and a beta of 1.49. Cognex has a twelve month low of $34.60 and a twelve month high of $72.88. The stock’s 50 day moving average price is $64.96 and its two-hundred day moving average price is $56.90.
Insider Activity at Cognex
In other Cognex news, insider Mark Fennell sold 64,873 shares of Cognex stock in a transaction on Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the completion of the transaction, the insider directly owned 11,263 shares of the company’s stock, valued at $755,184.15. The trade was a 85.21% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Laura Ann Macdonald sold 41,600 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $65.56, for a total value of $2,727,296.00. Following the sale, the vice president owned 5,258 shares of the company’s stock, valued at approximately $344,714.48. The trade was a 88.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 224,847 shares of company stock worth $14,975,098. Company insiders own 1.70% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of CGNX. Geneos Wealth Management Inc. lifted its position in Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after purchasing an additional 736 shares during the period. Elevation Wealth Partners LLC increased its holdings in Cognex by 635.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company’s stock valued at $35,000 after buying an additional 413 shares during the period. CIBC Private Wealth Group LLC raised its position in shares of Cognex by 74.8% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after buying an additional 327 shares in the last quarter. Cassaday & Co Wealth Management LLC bought a new stake in shares of Cognex during the 1st quarter worth approximately $36,000. Finally, Caitong International Asset Management Co. Ltd bought a new stake in shares of Cognex during the 4th quarter worth approximately $39,000. Institutional investors own 88.12% of the company’s stock.
About Cognex
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Read More
- Five stocks we like better than Cognex
- Why Analysts Are Bullish on a Stock That’s Down 20%
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
